Skip to main content
. 2021 Jun 1;9(6):659. doi: 10.3390/healthcare9060659

Table 1.

Baseline Demographic and Clinical Characteristics.

Participant Data Total Sample
(n = 55)
Treatment Group
(n = 25)
Active Control Group
(n = 30)
Demographic information
Female 58.2% (n = 32) 65.4% (n = 17) 51.7% (n = 15)
Age, yr 62.2 ± 12.0 58.7 ± 12.2 64.9 ± 11.2
Married/common law 38.2% (n = 21) 46.2% (n = 12) 30.0% (n = 9)
Level of education
Elementary School 9.1% (n = 5) 8.0% (n = 2) 10.3% (n = 3)
High school 38.2% (n = 21) 30.1% (n = 8) 44.8% (n = 13)
CEGEP (pre-university in Quebec) 18.2% (n = 10) 23.1% (n = 6) 13.8% (n = 4)
University 29.1% (n = 16) 30.1% (n = 8) 27.6% (n = 8)
Currently living alone 38.2% (n = 21) 26.9% (n = 7) 48.3% (n = 14)
Medical History
Number of medical problems 7.0 (IQR 5.0–8.0) 7.0 (IQR 5.0–8.0) 7.0 (IQR 5.0–9.0)
Number of years on dialysis 3.0 (IQR 1.0–7.0) 2.0 (IQR 1.0–5.0) 6.0 (IQR 1.0–9.0)
Number of current medications 10.0 (IQR 8.0–13.0) 9.0 (IQR 7.0–12.0) 11.0 (IQR 9.0–13.0)
Mental health information
History of psychiatric diagnosis 29.1% (n = 16) 32.0% (n = 8) 26.7% (n = 8)
Depression 18.2% (n = 10) 24.0% (n = 6) 13.3% (n = 4)
Anxiety 7.3% (n = 4) 4.0% (n = 1) 10.0% (n = 3)
Other 3.6% (n = 2) 4.0% (n = 1) 3.3% (n = 1)
Number of years since first diagnosis 15.0 (IQR 3.0–20.0) 4.0 (IQR 3.0–15.0) 17.0 (IQR 1.0–35.0)
Psychotropic medications 30.1% (n = 17) 28.0% (n = 7) 33.3% (n = 10)
Anti-depressant 25.5% (n = 14) 28.0% (n = 7) 23.3% (n = 7)
Anti-anxiety 9.1% (n = 5) 4.0% (n = 1) 13.3% (n = 4)
Currently receiving mental health follow-up 7.3% (n = 4) 11.5% (n = 3) 3.4% (n = 1)
Other
Habits (yes/no)
Smoking 14.5% (n = 8) 19.2% (n = 5) 10.3% (n = 3)
Alcohol consumption 23.6% (n = 13) 15.4% (n = 4) 30.0% (n = 9)
Recreational drugs 16.4% (n = 9) 19.2% (n = 5) 13.8% (n = 4)
Meditated before 18.2% (n = 10) 23.1% (n = 6) 13.8% (n = 4)
Meditates currently 10.9% (n = 6) 11.5% (n = 3) 10.3% (n = 3)